These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6541647)

  • 1. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Sim IS
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
    Freeman DJ; Sacks SL; De Clercq E; Spruance SL
    Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
    Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice.
    Park NH; Pavan-Langston D; Boisjoly HM; De Clercq E
    J Infect Dis; 1982 Jun; 145(6):909-13. PubMed ID: 6979592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice.
    Park NH; Pavan-Langston D; de Clercq E
    Antiviral Res; 1983 Mar; 3(1):7-15. PubMed ID: 6870230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
    de Clercq E; Zhang ZX; Sim IS
    Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Helbig B; Sauerbrei A; Klöcking R; Wutzler P; Wicht N; Wiedemann U; Herrmann G
    J Med Virol; 1987 Nov; 23(3):303-9. PubMed ID: 2828526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir treatment of experimental genital herpes simplex virus infections.
    Kern ER
    Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral BVDU treatment of varicella and zoster in children with cancer.
    Benoit Y; Laureys G; Delbeke MJ; De Clercq E
    Eur J Pediatr; 1985 Jan; 143(3):198-202. PubMed ID: 3987714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
    Wildiers J; De Clercq E
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):471-6. PubMed ID: 6539202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiherpetic activity of xylure].
    Chekunova EV; Marennikova SS; Mel'nik SIa; Preobrazhenskaia MN; Zaguliaeva OA
    Vopr Virusol; 1985; 30(4):444-6. PubMed ID: 3904209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
    De Clercq E
    Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
    de Clercq E; Degreef H; Wildiers J; de Jonge G; Drochmans A; Descamps J; de Somer P
    Br Med J; 1980 Nov; 281(6249):1178. PubMed ID: 7427624
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
    Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    de Clercq E
    Antimicrob Agents Chemother; 1984 Aug; 26(2):155-9. PubMed ID: 6486759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
    Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
    Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
    Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1983 Nov; 3(4):253-67. PubMed ID: 6320718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs.
    Nakano M; Kurokawa M; Hozumi T; Saito A; Ida M; Morohashi M; Namba T; Kawana T; Shiraki K
    Antiviral Res; 1998 Jul; 39(1):25-33. PubMed ID: 9754947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.